Sofinnova Revenue and Competitors

Location

N/A

Total Funding

Investments

Industry

Estimated Revenue & Valuation

  • Sofinnova's estimated annual revenue is currently $7.8M per year.(i)
  • Sofinnova's estimated revenue per employee is $143,767

Employee Data

  • Sofinnova has 54 Employees.(i)
  • Sofinnova grew their employee count by 2% last year.

Sofinnova's People

NameTitleEmail/Phone
1
Chief Compliance Officer & Chief Operating Officer, Public EquityReveal Email/Phone
2
CFO & PartnerReveal Email/Phone
3
VP FinanceReveal Email/Phone
4
VP FinanceReveal Email/Phone
5
Chief Legal OfficerReveal Email/Phone
6
Chief People OfficerReveal Email/Phone
7
Director IR and Marketing, Private EquityReveal Email/Phone
8
Menlo Park Office Manager& Executive AssistantReveal Email/Phone
9
San Diego Office Manager & Executive AssistantReveal Email/Phone
10
Executive Assistant & Office ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.8M240%N/AN/A
#2
$4.3M27-4%N/AN/A
#3
$1.9M14-22%N/AN/A
#4
$13.7M8734%N/AN/A
#5
$27M11928%N/AN/A
#6
$12.1M9358%N/AN/A
#7
$21.1M936%N/AN/A
#8
$23.4M85-11%N/AN/A
#9
$4.3M24-4%N/AN/A
#10
$7.6M45N/AN/AN/A
Add Company

What Is Sofinnova?

Sofinnova has been building Life Science and IT companies for over 30 years. We are constructive investors, assisting our portfolio companies with much more than money. Our mission is to create value by providing talented entrepreneurs with the resources, experience and network necessary to turn their bright ideas into great businesses.

keywords:N/A

N/A

Total Funding

54

Number of Employees

$7.8M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sofinnova News

2022-04-17 - Sofinnova Partners Announces New Investment in Nephris, an Innovative Biotech Targeting Chronic Kidney Diseases

Sofinnova Partners Announces New Investment in Nephris, an Innovative Biotech Targeting Chronic Kidney Diseases. Tue, April 19, 2022, 11:30 PM ·3 min read.

2022-03-30 - Biotech Investor Sofinnova Investments Adds Executive Partner

-based Sofinnova, the firm said. He most recently was chief medical officer of biotech startup Catamaran Bio Inc. and before that held the same...

2022-03-30 - Sofinnova Investments Announces the Addition of Dr. Chris ...

Since 1976, Sofinnova has been active in life science investing. We are a biopharmaceutical investment firm with approximately $3.0B in assets...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.2M5415%N/A
#2
$9.9M5510%N/A
#3
$15M55-4%N/A
#4
$14.1M56-29%N/A
#5
$8.3M56-18%$27.4M